MSLN and neoplasm: Trying to bypass the sMSLN-related tumor resistance to CAR-T cells, Liu and colleagues built an anti-MSLN CAR-T (15B6 CAR-T) with an Ab recognizing an MSLN epitope close to the membrane that is not affected by MSLN shedding.